Treatment of epidermal growth factor receptor inhibitor‐induced severe paronychia with pyogenic granuloma‐like lesions with topical betaxolol: an open‐label observation study-Reference-Cited by-同舟云学术

Treatment of epidermal growth factor receptor inhibitor‐induced severe paronychia with pyogenic granuloma‐like lesions with topical betaxolol: an open‐label observation study

Published:2019-11-25 Issue:3 Volume:59 Page:326-332
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Yen Chi‐Feng¹²,Hsu Chao‐Kai³⁴,Yang Hsing‐San³,Lee Chaw‐Ning³,Chi Ching‐Chi¹²,Chung Wen‐Hung¹²,Wang Chih‐Liang⁵,Pang Jong‐Hwei Su⁶⁷,Wang Chuang‐Wei¹²,Ko Yu‐Shien⁸,Lu Chun‐Wei¹²^ORCID

Affiliation:

1. Department of Dermatology Drug Hypersensitivity Clinical and Research Center Chang Gung Memorial Hospital Taoyuan Taiwan

2. College of Medicine Chang Gung University Taoyuan Taiwan

3. Department of Dermatology National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan

4. International Research Center of Wound Repair and Regeneration (iWRR) National Cheng Kung University Tainan Taiwan

5. Division of Pulmonary Oncology and Interventional Bronchoscopy Department of Thoracic Medicine Chang Gung Memorial Hospital Taoyuan Taiwan

6. Graduate Institute of Clinical Medical Sciences Chang Gung University Taoyuan Taiwan

7. Department of Physical Medicine and Rehabilitation Chang Gung Memorial Hospital Taoyuan Taiwan

8. Cardiovascular Division Microscope Core Laboratory Chang Gung Memorial Hospital Taoyuan Taiwan

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.14730

Reference24 articles.

1. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

2. The risk of nail changes with epidermal growth factor receptor inhibitors: A systematic review of the literature and meta-analysis

3. Management of egfr tki—Induced Dermatologic Adverse Events

4. Nail braces for severe paronychia induced by epidermal growth factor receptor inhibitors: An alternative to nail extraction

5. Nail toxicities induced by systemic anticancer treatments

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08

2. Is the combination of cryotherapy and topical timolol solution superior to cryotherapy alone in the treatment of epidermal growth factor receptor inhibitor-induced paronychia? A double-blinded, left-to-right comparison, randomized controlled trial;Journal of the American Academy of Dermatology;2023-11

3. Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan;Journal of Oncology Pharmacy Practice;2022-09-15

4. Kinesiology tapes wrapping for paronychia induced by epidermal growth factor receptor inhibitors: A pilot study;Dermatologic Therapy;2022-03-29

5. Dermatologic adverse events associated with epidermal growth factor receptor inhibitors: current concepts of interdisciplinary problem;Head and Neck Tumors (HNT);2022-02-14